Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Arctic Bioscience Report Publication Announcement 2023

Mar 29, 2023

3536_10-k_2023-03-29_a280c41c-a9ff-4020-bd47-841e98976790.html

Report Publication Announcement

Open in viewer

Opens in your device viewer

Arctic Bioscience - Annual report 2022

Arctic Bioscience - Annual report 2022

Arctic Bioscience has today released its Annual Report 2022, including the Board

of Directors report and financial statements. The report and annual accounts

were approved by the Board of Directors after close of business on 28[th] of

March 2023.

The report is attached to this stock notice and is available on the company's

website.

On Thursday 30 March 2023, at 12:00 CET, the Company will host a webcast to

present the results an give an operational update. Following the presentation,

it will be opened for questions from the audience.

Webcast details:

Date: Thursday 30 March 2023

Time: 12:00 CET

Format: Webcast and Q&A

Language: English

The presentation can be accessed through the Company's website, or with the link

below:

Link: https://channel.royalcast.com/landingpage/hegnarmedia/20230330_2/

Participants will be required to register to view the webcast and participate in

the Q&A.

This information is subject to the disclosure requirements pursuant to section 5

-12 of the Norwegian Securities Act.

For more information, please contact:

Christer L. Valderhaug

CEO

Phone: +47 920 84 601

E-mail: [email protected]

Jone R. Slinning

CFO

Mobile: +47 948 75 469

E-mail: [email protected]

About Arctic Bioscience

Arctic Bioscience is a biotech company developing and commercializing

pharmaceutical and nutraceutical products based on unique bioactive marine

compounds.

The company is developing HRO350 - a novel investigational drug candidate.

HRO350 is being developed for treatment of patients with mild-to-moderate

psoriasis. This is a large patient group in need of new effective medicines with

beneficial safety profile.

Nutraceuticals from Arctic Bioscience are sold globally as bulk ingredients as

well as finished goods under the ROMEGA® brand.

Arctic Bioscience is led by a team of highly competent people with experience in

developing marine oils and experience from global pharmaceutical companies.